Qualification

CA(SA), PhD (Commerce) Honoris Causa

Appointed

January 1999

Classification:

Executive director

Stephen is a founding shareholder of the Aspen Group and his responsibilities include strategic positioning and global transactions, geographic expansion and product diversification of Aspen in developed and emerging markets as a leading multinational pharmaceutical company.

Qualification

CA(SA)

Appointed

January 1999

Classification:

Executive director

Gus is a founding shareholder of Aspen and is responsible for the strategic and financial well-being of the Group while also identifying and pursuing appropriate corporate opportunities and global transactions that will further benefit Aspen and its stakeholders.

Qualification

MPhil (Oxon), BSocSci (Hons) (Natal), Global Leadership for the 21st Century Programme (Harvard), Foundations for Leadership in the 21st Century (Yale)

Appointed

April 2012

Classification:

Independent non-executive, Chairman

Kuseni is the Chairman of Massmart Holdings Limited. He was previously Chairman of Times Media Group Limited and Chief Executive Officer of Old Mutual South Africa and Emerging Markets. He brings a wealth of economic and business skills to the Board, having previously held positions as the head of Anglo American South Africa and Executive Chairman of Richards Bay Coal Terminal Company.

Kuseni is the former Chairman of the South African National Parks and a former member of the Global Agenda Council on Economic Growth and Poverty Alleviation formed by the World Economic Forum. He is active in academic and professional bodies, which include the Council of the University of Pretoria, the South African Institute of International Affairs, and the advisory boards of the Gordon Institute of Business Science and Common Purpose.

Kuseni is a member of the Remuneration & Nomination Committee.

Qualification

CA(SA), MCom (Tax), CD(SA)

Appointed

July 2018

Classification:

Independent non-executive

Linda serves as an independent non-executive director on a number of JSE listed boards, namely Momentum Metropolitan Holdings Limited, Tongaat Hulett Limited and Shoprite Holdings Limited. She chairs or serves on the audit committees of these boards and also serves on a number of their other board committees. She was previously a member of numerous South African and international standard setting, oversight and corporate governance structures. In addition, chairs the board of trustees of the International Public Interest Oversight Board (PIOB), a non-profit foundation in Spain, and serves as a trustee of the International Valuations Standards Council (based in London).

Linda serves as the Chair of the Remuneration & Nomination Committee and is a member of the Audit & Risk Committee.

Qualification

BCom (Hons), CA(SA), Advanced Programme in Management (Harvard Business School)

Appointed

April 2019

Classification:

Lead independent non-executive

Ben joined Standard Merchant Bank in 1985 and, after having fulfilled various leadership roles in corporate and investment banking, was appointed as Chief Executive of Standard Bank Corporate and Investment Banking in 2001. In March 2013, Ben was appointed as Co-Chief Executive Officer of the Standard Bank Group Limited, and he retired from The Standard Bank Group on 31 December 2018. He currently serves as a non-executive director on the board of Stanbic IBTC Holdings Plc and Stanbic IBTC Bank Plc and as a non-executive director on the board of the JSE Limited. He is a member of the Institute of Directors of Southern Africa and served on the board of the International Institute of Finance. Ben is also a member, and serves as Deputy Chair, of the Council of the University of Pretoria.

Ben is a member of the Audit & Risk Committee and Social & Ethics Committee.

Qualification

B.Eng (Hons)

Appointed

April 2019

Classification:

Independent non-executive

Themba was appointed as the Chief Executive Officer of Kumba Iron Ore Limited, a member of the Anglo American Plc Group, in September 2016. Prior to this appointment, he held several senior executive positions at various companies, including Anglo American Coal South Africa, Rio Tinto Technology and Innovation, Rio Tinto Australia and Huntsman Tioxide Southern Africa.

Themba is a member of the Remuneration & Nomination Committee.

Qualification

BA, LLB

Appointed

January 1999

Classification:

Non-executive

Chris has been a full-time practising attorney since 1988 and has substantial legal and commercial expertise. His intimate knowledge of the Group, its business operations and governance processes have been of immense benefit to Aspen over the years and he continues to serve the Board as a trusted adviser. As Chris’s firm is intermittently called upon to provide legal advice to the Group, he is classified as a non-independent non-executive director.

Qualification

CA(SA), MBA, Higher Diploma in Banking Law (RAU)

Appointed

April 2016

Classification:

Independent non-executive

Babalwa is the CEO of Sinayo Securities (Pty) Limited, a women-owned and managed securities firm, and the Chairperson of University of Cape Town Council. Prior to this, she held positions as the Group Chief Internal Auditor of Nedbank Limited, Chief Financial Officer of Safika Holdings (Pty) Limited, partner at Deloitte (Financial Institutions Services Team and Chairperson of the Transformation Advisory Board). She is, among others, a non-executive director and chairperson of the audit committees of Vukile Property Fund Limited, and formerly of Barloworld Limited non-executive director and Implats Limited lead independent director, and therefore brings considerable financial and commercial experience to the Board. Babalwa is also a lead independent director and chairperson of the risk and IT committee of Hollard Life Assurance Limited and The Hollard Insurance Company Limited. In August 2008, she received an award as a BBQ business woman visionary. Babalwa was a member of the Education and Academic Review Committees of the South African Institute of Chartered Accountants (“SAICA”), she was the founding Chairman of the African Women Chartered Accountants (“AWCA”), and currently a member of its Advisory Board.

Babalwa is the Chair of the Audit & Risk Committee.

Qualification

BSc (Hons), CA

Appointed

February 2015

Classification:

Non-executive * British

David was appointed Chief Strategy Officer of GlaxoSmithKline Plc (“GSK”) in May 2008 and is responsible for corporate development and strategic planning. He has, in this role, assisted GSK in numerous bolt-on acquisitions, disposals and joint ventures, including the creation of the world-leading Consumer Healthcare company through the combination of GSK, consumer healthcare business firstly with Novartis’s business and subsequently in 2019 with Pfizer’s business. He is a member of GSK’s Corporate Executive Team and reports to the CEO. Prior to holding this position, he was responsible for the leadership of GSK’s business in Northern Europe from 2005 to 2008 and Central and Eastern Europe from 2002 to 2005. He joined Glaxo in 1994 in finance and progressed through a series of finance roles before becoming Finance Director of the European business in 1999.

In addition to his current role, David is Chairman of ViiV Healthcare Limited. ViiV is a joint venture between GSK, Pfizer and Shionogi and focuses specifically on the research and development and global commercialisation of medicines to treat HIV.

Qualification

CA(SA), CD(SA), Advanced Taxation Certificate (UNISA), Advanced Diploma in Financial Planning (UOFS) and Advanced Diploma in Banking (RAU)

Appointed

September 2006

Classification:

Independent non-executive

Sindi is the co-founder and retired Chief Executive Officer of Nkonki Incorporated, having held the position from 1998 until her retirement through a management buyout in 2016. A Chartered Accountant by profession, Sindi is an expert in the areas of accounting, auditing and business management. Sindi is also a Chartered Director (SA) and has vast experience as a director in the public and private sectors, currently serving as a non-executive director of Discovery Holdings Limited, Metrofile Limited and Mercedes-Benz SA (debt listed). Her unlisted company boards include Tourvest Group and Gijima Limited. She is an author of “The ACE Model-Winning Formula for Audit Committees” and the author of “Creating Board and Committee Effectiveness”. She is a member of the South African Institute of Chartered Accountants and the Institute of Directors and is a guest lecturer at the GIBS Corporate Governance and Leadership Elective Course. Sindi was previously non-executive Chairman of Airports Company South Africa and a non-executive director of Woolworths Limited, Primedia Limited, Wiphold Limited, Ethos Private Equity, Institute of Directors, Alexkor Limited, Rebosis Limited, ATNS SOC Limited and previously chaired the BUSA Standing Committee on Transformation.

Sindi serves as Chair of the Social & Ethics Committee.

Qualification

CA(SA), PhD (Commerce) Honoris Causa

Appointed

January 1999

Responsibilities:

Stephen is a founding shareholder of Aspen. His responsibilities include the strategic positioning of Aspen as a leading multinational pharmaceutical company, global transactions, geographic expansion and product diversification of Aspen in emerging and developed markets.

Qualification

CA(SA)

Appointed

January 1999

Responsibilities:

Gus is a founding shareholder of Aspen and is responsible for the strategic and financial well-being of the Group while also identifying and pursuing appropriate corporate opportunities and global transactions that will further benefit Aspen and its stakeholders.

Qualification

CA(SA)

Appointed

January 1999

Responsibilities:

Sean is responsible for all of the Group’s finance functions across Aspen’s 60 businesses. He also assesses business performance and identifies business improvement opportunities.

Qualification

BCom (Human Resources)

Appointed

August 2017

Responsibilities:

Richelle is responsible for the overall operations of Aspen’s South African Commercial Pharmaceutical business, including SADC countries. She provides executive leadership across this organisation, including overall strategic direction, and leads new business development and opportunities.

Qualification

MBA, PGDBA, Graduate Diploma in Company Direction

Appointed

May 2020

Responsibilities:

Reginald is responsible for managing Aspen’s cluster of Group Corporate Services functions. He also ensures the provision of efficient and effective services to the Group in accordance with business and legislative requirements. Reginald was appointed as a member of the Social & Ethics Committee on 1 September 2020.

Qualification

BPharm

Appointed

January 1999

Responsibilities:

Lorraine is responsible for multiple operational areas of the business, including strategic manufacturing, pharmaceutical affairs, new product development and strategic procurement. In addition, she plays an integral role in negotiation and implementation of new business initiatives for the Manufacturing business, which she also represents in global transactions.

Qualification

CMA, CFM, CBM, MBA

Appointed

May 2008

Responsibilities:

Samer joined the Group with the responsibility of establishing the company to lead and direct its international operations. He has been integrally involved in the negotiation, completion and integration of strategic acquisitions, the setting up of the Group’s global businesses as well as the trading and supply structures to support these.

Qualification

CA(SA), CFA

Appointed

May 2020

Responsibilities:

Zizipho is responsible for focusing on assessing and implementing strategic development activities for the Group such as acquisitions, disposals and collaborations. She also plays an active role in advancing business performance and value enhancement opportunities.

Qualification

B.Pharm, FPS (SA), PhD (Medicine) Honoris Causa

Appointed

January 1999

Responsibilities:

Stavros plays a pivotal role in the initiation of business development opportunities and is also key to the building and maintenance of strategic relations within industry and with all of Aspen’s stakeholders.

Qualification

CA(SA)

Appointed

May 2001

Responsibilities:

Trevor is responsible for the implementation of strategy and the performance delivery of Aspen’s Commercial Pharmaceutical businesses in Australasia, the Philippines, Taiwan, Malaysia and Hong Kong as well as trade into the rest of the Asia Pacific region. He plays a leading role in all transactional activity in the region.